Skip to content
  • There are no suggestions because the search field is empty.
  • There are no suggestions because the search field is empty.
  • There are no suggestions because the search field is empty.
featured-image

Stroke

AI

The Impact of Automated Software on Alberta Stroke Program Early CT Score

The Alberta Stroke Program Early CT Score (ASPECTS) is essential for clinical decision-making when treating ischemic stroke patients. It helps measure early ischemic changes and predict the functional outcome of endovascular thrombectomy.
featured-image

Aneurysm

AI

Advanced Imaging

Funding brain aneurysm research: Q&A with Christine Buckley of the Brain Aneurysm Foundation

RapidAI is proud to partner with the Brain Aneurysm Foundation (BAF) and support its mission to promote early detection of brain aneurysms by raising awareness of the signs, symptoms, and risk factors.
featured-image

Stroke

AI

Advanced Imaging

Neurovascular imaging for patients with suspected transient ischemic attack

Approximately 240,000 people in the United States experience a transient ischemic attack (TIA) annually. A TIA is a stroke lasting only a few minutes when the blood supply to part of the brain is briefly interrupted.
featured-image

Stroke

Workflow

AI

Mastering the Art of Patient Transfer: Utilizing RapidAI Software for Seamlessly Transferring Patients to a Different Hospital

Neuroimaging has played a significant role in the stroke workflow following the DAWN and DEFUSE 3 trials and revised guidelines for acute ischemic stroke treatment. It helps determine which patients are eligible for endovascular thrombectomy (EVT) in the late window.
featured-image

Stroke

AI

Advanced Imaging

Optimal patient selection for endovascular thrombectomy procedure: CT Perfusion versus Non-contrast CT

Landmark stroke clinical trials DAWN and DEFUSE 3 helped validate the benefits of endovascular thrombectomy (EVT) procedure in acute ischemic stroke patients (AIS) in the late window. CT perfusion (CTP) aided in selecting eligible patients with a favorable perfusion profile.
featured-image

Stroke

AI

Neuroprotectant ApTOLL reduced death and disability in acute ischemic stroke patients

ApTOLL, a neuroprotective agent, has shown promising results in the APRIL 1b/2a trial and reduced death and disability when used alongside standard treatment in selected ischemic stroke patients. Rapid CTP helped with patient selection and mismatch determination.
featured-image

Stroke

Workflow

Advanced Imaging

Intracranial hemorrhage management with Rapid software

Rapid ICH 3.0 and Rapid Hyperdensity represent the best-in-class hemorrhagic solutions supporting clinicians managing intracranial hemorrhage (both hemorrhagic stroke and head trauma). Two studies presented at the International Stroke Conference (ISC) 2023 provide further clinical evidence of the value of these technologies.
featured-image

Stroke

Safety and efficacy of tenecteplase treatment in wake-up stroke patients screened using non-contrast CT

Based on current evidence, treatment with intravenous alteplase is recommended for patients with DWI-FLAIR mismatch or perfusion mismatch on CT or magnetic resonance perfusion. However, emergency rooms may have limited access to MRI or perfusion imaging.
featured-image

Stroke

Advanced Imaging

Mediators of successful reperfusion effect in ischemic stroke patients

Pivotal trials helped establish the role of endovascular thrombectomy (EVT) treatment for selected ischemic stroke patients with large vessel occlusions. However, not all patients undergoing EVT receive functional independence.
1 2